SOLICITATION NOTICE
R -- Developing a SEER Survival Calculator
- Notice Date
- 5/16/2011
- Notice Type
- Presolicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-110068-MW
- Archive Date
- 6/15/2011
- Point of Contact
- Melissa R. Ward, Phone: 301-402-4509, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
wardmr@mail.nih.gov, cr214i@nih.gov
(wardmr@mail.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Boulevard, EPS Suite 600, Room 6072, Rockville, MD 20852, UNITED STATES. Description The National Cancer Institute (NCI), Division of Cancer Control & Population Sciences (DCCPS), plans to procure on a sole source basis with the Cancer Prevention Institute of California (CPIC), 2201 Walnut Ave., Suite 300, Freemont, CA 94538 for developing a clinically useful SEER survival calculator for breast cancer. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1). The North American Industry Classification System Code is 541690 and the business size standard in $7.0M. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Period of Performance: Performance shall be for twelve months from date of award with one twelve month option period. NCI's Surveillance, Epidemiology, and End Results (SEER) data represent an important source of complete, population-based information regarding survival after cancer. NCI and SEER recently developed an online prototype targeted to clinicians, the Cancer Survival Query System (CSQS), a "survival calculator" which displays detailed and co-morbidity-adjusted SEER survival data for colorectal and prostate cancer patients. Adapting these existing NCI tools to display survival data for breast cancer and its subtypes could be very useful in the breast care setting, but it remains uncertain how to structure these tools so they best meet the needs of practicing breast surgeons and oncologists. The contractor shall provide specifications needed for NCI to implement an online "survival calculator" displaying detailed, co-morbidity adjusted SEER survival data for breast cancer patients, targeted towards physicians' needs and preferences. The contractor shall demonstrate the calculator and assess its utility among clinicians. CPIC has participated in several successful multidisciplinary efforts to reconsider the most effective dissemination of SEER data to particular audiences. The study team CPIC, formerly the Northern California Cancer Center, has full access to the human, laboratory, informatics, and intellectual resources necessary to successfully complete this project; these resources are described below. Briefly, these resources include the Greater San Francisco Bay Area's population-based NCI SEER cancer registry and its associated staff with strong expertise in the use and dissemination of SEER data, especially in clinical settings; appropriate, state-of-the-art computer hardware and software and associated technical support from the CPIC Information Services/Information Technology (IS/IT) staff. Other important resources include access to the Stanford Cancer Center core facilities, including the Biostatistics Core, and other Stanford University resources, including a full complement of scientific and medical literature from the Stanford University libraries and collections. The physical location of the CPIC offices, in the heart of the San Francisco Bay Area, enables easy access to and from other local research organizations, including Stanford University, University of California, Berkeley, University of California, San Francisco, Kaiser Division of Research, and the Palo Alto Medical Foundation Research Institute. Thus, all aspects of this environment and its resources ideally position this team to lead the proposed project. One key to their unique capability is the fact that the California cancer registries are the only population-based registries to have included HER2 status for breast cancer patients starting in cases diagnosed in 2005 and after (and in a limited capacity prior to 2005). The remaining registries are including HER-2 starting in cases diagnosed in 2010 and after. HER-2 is a critical prognostic variable to include in the survival models, and having that variable going back a number of years is a unique and necessary asset. In addition CPIC has assembled a team that has expertise in the coding of breast cancer in the SEER registries and expertise in the analysis and interpretation of comorbidity data, with a long history of research in both areas. Finally, CPIC is unique in its collaboration with the ATHENA Breast Care Network (http://www.athenacarenetwork.org/ ) which has been identified as a unique network across all 5 University of California medical centers, whose aim is to unite California women, physicians, and researchers in an effort to personalize breast cancer prevention, screening, and treatment. CPIC's collaboration with the Athena Network will allow for: (1) a unique ability to test the CSQS is a cutting edge breast cancer health care program, and (2) explore the possibilities of incorporating the CSQS as a dashboard tool as part of their electronic medical record system. No other sources with this unique combination of attributes which are needed to insure the objectives of this study are known to NCI. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on May 31, 2011. No electronic capability statements will be accepted (i.e. email or fax). An original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed (301) 402-4513 or emailed to Melissa Ward, Contract Specialist, at wardmr@mail.nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) www.ccr.gov and the Online Representations and Certifications Applications (ORCA), http://orca.bpn.gov. No collect calls will be accepted. Please reference solicitation number NCI-110068-MW on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-110068-MW/listing.html)
- Record
- SN02448311-W 20110518/110516234123-955a49100c15dcc3916a620c858d8014 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |